Novartis’ PI Motion re Gilenya® Denied: Generic Entry Does Not Necessarily Cause “Catastrophic Damages” to the Brand

1 min. read

The Israeli Tax Authority has issued groundbreaking guidance on SAFE instruments, providing much-needed clarity for venture capital investments. Our client update explores the new safe harbor provisions, key compliance conditions, and practical implications for startups and investors navigating Israel’s evolving tax landscape. Essential reading for the venture ecosystem.

Published in

you might be interested in

Articles

S. Horowitz’s chapter on Israel in the Law Over Borders: Global M&A Guide for 2026 covers market trends, deal structures, and key focal points shaping Israeli M&A.

Updates

Articles

Partner Benjamin Sheffer and Advocate Of Counsel Lance Blumenthal from S. Horowitz, provide a full legal overview of Israeli construction law.

Subscribe

Get the latest updates straight to your inbox

SHARE

Facebook
LinkedIn
WhatsApp
Email
Print